1 credit on prescribing opioids and/or benzodiazepines;
50% of CME hours must be in the physician's primary area of practice.

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://www.healthy.arkansas.gov/programs-services/topics/arkansas-state-medical-board

All APRNs issued a certificate of prescriptive authority after December 31, 2015, shall obtain a minimum of three (3) hours of prescribing education which includes information on maintaining professional boundaries and the prescribing rules, regulations, and laws that apply to APRNs in the state within two (2) years of issuance of the prescriptive authority certificate (ASBN Rules, Chapter 4, Section VIII, A.7.). In order to meet this requirement, you will need to complete two courses, Advanced Practice Nursing in Arkansas (2 contact hours) and Prescription Drug Misuse and Abuse (1 contact hour).

(5) hours each biennium in pharmacotherapeutics in the APRN’s area of certification (for those with prescriptive authority);
(2) of these prescribing hours must contain information related to maintaining professional boundaries and the prescribing rules, regulations, and laws that apply to APRNs in Arkansas (ASBN Rules, Chapter 4, Section III,F.7.). In order to meet this requirement, you will need to complete the course Advanced Practice Nursing in Arkansas (2 contact hours).

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://www.healthy.arkansas.gov/programs-services/topics/arsbn-adv.-practice

(5) hours on pain management (if authorized to prescribe Schedule II hydrocodone combination products reclassified from Schedule 3 to Schedule 2);
(1) hour on prescribing of opioids and benzodiazepines.

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://www.healthy.arkansas.gov/programs-services/topics/arkansas-state-medical-board
https://casetext.com/regulation/arkansas-administrative-code/agency-007-arkansas-department-of-health/division-33-division-of-health-related-boards-and-commissions/rule-0073322-010-rule-24-physician-assistants